LXEO logo
LXEO NASDAQ US

Lexeo Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2023
$5.72
▲ +$0.05 (+0.88%)
Vol 626K
4
Quality Score
fail
Mkt Cap
$724.8M
ROE
-90.5%
Margin
-11991.8%
D/E
0.85
Beta
2.07
52W
$1–$11

Wall Street Consensus

17 analysts · Apr 2026
8
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
94.1%
Buy Rating

Price Chart

Similar Stocks

MYGN
Myriad Genetics Inc
$573.3M
RGNX
Regenxbio Inc
$729.0M
ALT
Altimmune Inc
$376.7M
AURA
Aura Biosciences Inc
$346.1M
VNDA
Vanda Pharmaceuticals Inc
$521.2M
AVTX
Avalo Therapeutics Inc
$329.3M
STRO
Sutro Biopharma Inc
$98.6M

Earnings

Beat rate: 80.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.32 $-0.27 +$0.05
Sep 2025 $-0.53 $-0.33 +$0.20
Jun 2025 $-0.69 $-0.60 +$0.09
Mar 2025 $-0.80 $-0.99 $-0.19

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -94.7% -94.7% -94.7% -94.7% -90.5% -90.5%
P/E (TTM) — — — — — —
Net Margin — -11991.8% -11991.8% -11991.8% -11991.8% -11991.8%
Gross Margin — — — — — —
D/E Ratio 0.79 0.79 0.79 0.79 0.85 0.85
Current Ratio 4.43 4.43 4.43 4.43 7.40 7.40

Key Ratios

ROA (TTM)
-70.9%
P/S (TTM)
535.16
P/B
1.9
EPS (TTM)
$-2.70
CF/Share
$-2.56
52W High
$10.99
52W Low
$1.45
$1.45 52-Week Range $10.99

How does LXEO compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

LXEO AAPG ABEO ABOS ABP

LXEO valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
535.2
▲ 4065% above peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.9
▼ 24% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

LXEO profitability vs Biotechnology peers

ROE
-90.5%
▼ 34% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-11991.8%
▼ 4082% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-70.9%
▼ 52% below peers (-46.7%)
vs Peers
vs Industry
Weak

LXEO financial health vs Biotechnology peers

D/E ratio
0.9
▼ 0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
7.4
▲ 67% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.1
▲ 113% above peers (1.0)
vs Peers
vs Industry
More volatile

LXEO fundamentals radar

LXEO Peer median Industry

LXEO profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

LXEO vs peers: key metrics

Latest News

No related news yet